about
Safety of topical corticosteroids in pregnancyInterventions for managing asthma in pregnancyInterventions for managing asthma in pregnancySafety of topical corticosteroids in pregnancyCongenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guidelineA Systematic Review and Meta-Analysis of the Utility of Corticosteroids in the Treatment of Hyperemesis GravidarumUse of inhaled and oral corticosteroids in pregnancy and the risk of malformations or miscarriageManaging inflammatory bowel disease in pregnancy: current perspectivesChallenges and treatment options for rheumatoid arthritis during pregnancy.Autoimmune blistering diseases in females: a review.Maternal stressors and social support as risks for delivering babies with structural birth defects.A metabonomic approach to analyze the dexamethasone-induced cleft palate in mice.First-trimester nonsystemic corticosteroid use and the risk of oral clefts in Norway.Is it safe to use inhaled corticosteroids in pregnancy?Review article: acute severe ulcerative colitis - evidence-based consensus statements.Management of envenomations during pregnancy.Investigating Women's Experiences of Asthma Care in Pregnancy: A Qualitative Study.Corticosteroid use and risk of orofacial clefts.Corticosteroid use during pregnancy and risk of orofacial cleftsGENES AS INSTRUMENTS FOR STUDYING RISK BEHAVIOR EFFECTS: AN APPLICATION TO MATERNAL SMOKING AND OROFACIAL CLEFTSMedications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects.A comprehensive review of the genetic basis of cleft lip and palateDescriptive and risk factor analysis for choanal atresia: The National Birth Defects Prevention Study, 1997-2007Topical corticosteroid use during pregnancy.A preliminary study on the teratogenesis of dexamethasone and the preventive effect of vitamin B12 on murine embryonic palatal shelf fusion in vitro.Safety and efficacy of immunomodulators and biologics during pregnancy and lactation for the treatment of inflammatory bowel diseaseEnvironmental factors related to the occurrence of oral clefts in a Brazilian subpopulation.Risk of miscarriage among users of corticosteroid hormones: a population-based nested case-control studyAdrenal Cushing's syndrome in pregnancy: Clinical and molecular characterisation of a case.Diabetes mellitus and drug abuse during pregnancy and the risk for orofacial clefts and related abnormalitiesMaternal corticosteroid use and hypospadias.Management of early aggressive rheumatoid arthritis during pregnancy and lactation.Management of RA medications in pregnant patients.European evidenced-based consensus on reproduction in inflammatory bowel disease.Hyperemesis gravidarum: pathogenesis and the use of antiemetic agents.Ear, nose, and throat manifestations during pregnancy.Evidence-based (S3) guideline on topical corticosteroids in pregnancy.Rheumatoid arthritis and pregnancy: safety considerations in pharmacological management.Pregnancy and renal outcomes in lupus nephritis: an update and guide to management.IBD medications during pregnancy and lactation.
P2860
Q24186366-9826AEA2-375F-4563-A64D-E8769ADE1BA6Q24193088-78C5017B-BD95-4C1C-8B41-1445232FFDF3Q24201592-B1BFB231-621D-464C-B8E0-40FC1E030948Q24240069-3B850007-214F-4A29-812D-7D99216ED62AQ24614223-C7CBE9C3-A042-46C2-A738-AD817F93CC87Q26766095-9972E408-FFF1-4DA3-A451-8FBB8299C503Q26825323-ADB81813-8D62-40B6-9B3C-2509F8D7EAF4Q28068318-6B5180A9-54B6-4284-BD1E-9C6484685F02Q30249730-8630BB98-F333-4709-A9A2-A7D0F98F45CDQ33640302-84A8C54C-0D2E-4FE1-8FDA-6CD501D66F42Q33754005-E2A2B30B-8282-45FF-8E75-E0F917C2D2E3Q34097466-5C861AEB-088E-4593-B50F-016470D1F5C0Q34169484-610D1CCE-2D15-41C5-AD0B-F39A2994D584Q34173043-B869DF3C-4E57-44A3-8BB1-3F7D05D796AFQ34528270-8CC24468-BC75-49BF-9AC4-ECD385E33597Q34539269-D31BDA2F-46E1-40BD-A898-3CADCA468E9CQ34675331-2D85103D-23CF-430F-8FD4-1E699BAAE9DCQ34819115-53B6F3AD-E8BF-469E-9749-E313B38B50EEQ34828505-1A52D51E-485C-4211-9122-C600CB31ABCBQ35549920-188FB25D-28BC-4A39-84F5-D98A831C97B6Q35820722-21BEEC48-5CAA-4433-A364-912FB4211448Q35829617-2D4A77FF-6512-44F8-999A-2000EBE3E3E2Q35903277-A4C6AAAE-F812-416E-9C5C-81F457E44BECQ36030246-C3104D29-063A-43E4-A45D-D8AA1621A02AQ36513012-B5C7BA74-EA82-4267-ADA4-D52ED442B4EAQ36989959-C55BCB87-5597-4662-9450-5759A5C511C5Q37045635-DF180B2D-6D8C-4337-AFB2-6B85A92D7844Q37106222-612D7451-3210-437B-855F-E4EDBCAD113AQ37107360-6C83A24D-617E-4F6C-8198-49F0CB445567Q37186983-4129D2EE-ED04-466B-89BC-A9610BCB875BQ37393747-9FB32BBA-EF09-4E19-B2E0-520A9CF56946Q37510901-BD66345E-EA1C-4B44-958D-2B8C2C3FC825Q37511730-F30515DB-7229-45C1-A295-5D5AC34CDCE5Q37814564-6C6EE038-B79C-4759-9374-82162EF13B5AQ37848438-DB286720-1958-4E28-A816-5BB700DDE73EQ37873692-887BDA25-628D-43E4-BA64-0CF111184FD7Q37897623-13421097-A83E-4BD5-9A82-4B2ED4659ADEQ37943826-048B27C1-F8F6-47B6-9C7E-CBBAED1DD1C2Q38033398-6F392E96-459A-462F-8C8D-C94946EEB3FBQ38125114-BC8506B6-A0A2-42B8-8C32-4D839C3FBB7E
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Maternal corticosteroid use and orofacial clefts.
@en
Maternal corticosteroid use and orofacial clefts.
@nl
type
label
Maternal corticosteroid use and orofacial clefts.
@en
Maternal corticosteroid use and orofacial clefts.
@nl
prefLabel
Maternal corticosteroid use and orofacial clefts.
@en
Maternal corticosteroid use and orofacial clefts.
@nl
P2093
P50
P1476
Maternal corticosteroid use and orofacial clefts.
@en
P2093
Edward J Lammer
Sonja A Rasmussen
P304
585.e1-7; discussion 683-4, e1-7
P356
10.1016/J.AJOG.2007.05.046
P407
P577
2007-12-01T00:00:00Z